Ductal carcinoma in situ with and without microinvasion: is there a clinically meaningful difference in outcome?

Br J Cancer. 2023 Mar;128(5):713-714. doi: 10.1038/s41416-023-02152-x. Epub 2023 Jan 27.

Authors

Rita Canas-Marques¹, Stuart J Schnitt²

Affiliations

¹ Department of Pathology, Champalimaud Foundation, Lisboa, Portugal.
² Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Breast Oncology Program, Dana-Farber Cancer Institute, Boston, MA, USA. sschnitt@bwh.harvard.edu.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Breast Neoplasms*
Carcinoma in Situ* / pathology
Carcinoma, Ductal, Breast* / pathology
Carcinoma, Intraductal, Noninfiltrating* / pathology
Female
Humans
Neoplasm Invasiveness